Workflow
傲农生物: 福建傲农生物科技集团股份有限公司第四届董事会第十六次会议决议公告

Core Viewpoint - The company held its 16th meeting of the 4th Board of Directors on June 24, 2025, where several key resolutions were passed to enhance corporate governance and investor relations [1][2][3]. Group 1: Corporate Governance Enhancements - The company approved the establishment of a "Market Value Management System" to improve investment value and enhance investor returns [2]. - The company revised the "Investor Relations Management System" to strengthen communication with investors and protect the rights of minority shareholders [2]. - The company updated the "Information Disclosure Management System" to ensure compliance with legal requirements and protect the interests of shareholders and creditors [3]. Group 2: Internal Reporting and Compliance - The company revised the "Major Information Internal Reporting System" to clarify information collection and management procedures [4]. - The company updated the "Insider Information Knowledge Person Registration Management System" to enhance confidentiality and prevent insider trading [5]. - The company revised the "Information Disclosure Suspension and Exemption Management System" to ensure compliance with disclosure obligations [5]. Group 3: Audit and Financial Reporting - The company revised the "Board Audit Committee Annual Report Work Regulations" to improve the quality of financial reporting and enhance the supervisory role of the audit committee [6]. - The company updated the "Major Error Responsibility Accountability System for Annual Report Disclosure" to increase accountability for disclosure accuracy [6]. - The company revised the "Fundraising Management Measures" to enhance the management and utilization of raised funds [7]. Group 4: Management and Operational Procedures - The company revised the "Board Secretary Work System" to clarify the responsibilities and procedures for the board secretary [7]. - The company updated the "Internal Audit System" to improve audit quality and risk control [8]. - The company revised the "Accountant Firm Selection System" to ensure the integrity of financial information and protect shareholder interests [9]. Group 5: Risk Management and Hedging - The company approved the "Hedging Business Management System" to regulate futures and derivatives trading [12]. - The company authorized a maximum trading margin and premium limit of RMB 140.05 million for hedging activities, with a maximum contract value of RMB 1.27 billion on any trading day [12].